Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Intervention1: Drugs namely Suranjan (ColchicumLuteum), Khulanjan (Alpinia Galanga) and Bozidan (Pyrethrum Indicum): The drugs will be ground into fine powder then 5 grams of the drug will be given th
Sponsors
Islamic University of Science and Technology
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either sex will be selected for the study. 2.Between 18 to 60 years of age. 3.Fulfilling the criteria of American College of Rheumatology for diagnosing Gouty Arthritis including clinical features, laboratory, and radiological finding will be included in the study, who had serum Uric Acid level more than 7mg/dl.
Exclusion criteria
Exclusion criteria: 1.Patients below 18 and above 60 years of age. 2.Pregnant and Lactating mothers. 3.Patients who fail to give consent. 4.Patients of Gout associated with any systemic disorder which interfere with patient study will be excluded. 5.Patients of Gout associated with any severe Arthritis condition. Such as Rheumatoid arthritis, Septic arthritis will be excluded from the study 6.Patients suffering from Anemia and other blood dyscrasias like leukemia, hemophilia etc 7.Patients with history of suffering with congenital Gout.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Serum uric acid level. 2.CRP 3.ESR Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Pain Tenderness and Swelling in the affected joints 2 Difficulty in movement. 3 Affected joint redness (Erythema). Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Tabasum Fatima
Islamic University of Science and Technology
Outcome results
None listed